CN101199793B - Chinese medicine compound oral administration for treating lumbar hyperosteogeny - Google Patents
Chinese medicine compound oral administration for treating lumbar hyperosteogeny Download PDFInfo
- Publication number
- CN101199793B CN101199793B CN2007101152868A CN200710115286A CN101199793B CN 101199793 B CN101199793 B CN 101199793B CN 2007101152868 A CN2007101152868 A CN 2007101152868A CN 200710115286 A CN200710115286 A CN 200710115286A CN 101199793 B CN101199793 B CN 101199793B
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- rhizoma
- treatment
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral Chinese traditional medicine combination for treating lumbar vertebrae hyperosteogeny, belonging to the Chinese traditional medicine field. The Chinese traditional medicine combination is prepared by Spina Gleditsiae, Radix Clematidis Chinensis, Radix Glycyrrhizae, Radix Rehmanniae, Radix Paeoniae, Rhizoma Sparganii, Eupolyphaga Seu Steleophaga, Rhizoma Curcumae Longae, Harms Manyprickle Acanthopanax, Rhizoma Drynariae and Caulis Spatholobi which are prepared in a certain weight proportion. The drugs are decocted with water and taken by two times for one day, and one month is one period of treatment. The efficacies of the drugs cooperate to perform the functions of promoting spurs to be softened and shrunk, thereby the invention can critically treat the lumbar vertebrae hyperosteogeny.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of lumbar vertebra hyperosteogeny, is a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration specifically, belongs to the field of Chinese medicines.
Background technology
The ligament that plays elastic reaction on the vertebrae after people in middle age begins to relax, and the cartilage and the intervertebral disc that play cushioning effect begin to degenerate, and the regulative mechanism of human motion itself, compensatory ground grow biological this of some chelas and be called hyperosteogeny at the vertebra edge.Along with society steps into aging, the hyperosteogeny of middle-aged and elderly people increases year by year, but lumbar vertebra hyperosteogeny is with beyond the change of age, also whether the long-term over-drastic factors such as activity and heavy burden damage of bending and stretching are relevant with lumbar vertebra, picture some must sitting, station for a long time, as cybraian, teacher, accounting, the driver, the isometric time of typewriting keeps same posture work group and also all lumbar vertebra hyperosteogeny may take place.The lumbar vertebra hyperosteogeny early symptom only shows as waist and leg ache, sitting, tired back or morning time-out pain obvious, suitably movable or have a rest after alleviate.Behind intervertebral disc degeneration, conscious waist is stiff when movable, and pain is unable.In case hypertrophy makes the spinal nerves pressurized, can cause the radiating pain of waist, also lumbago and skelalgia and numbness of lower limbs can appear.Doctor trained in Western medicine adopts non-hormone antiinflammation pain-stopping pharmaceutical, physical therapy and operative treatment at present, relief of symptoms is had certain effect, but still do not have special effective therapy so far.Adopt the traditional Chinese medical herbal treatment lumbar vertebra hyperosteogeny to have the comprehensive effect of activating blood circulation to dissipate blood stasis, supplementing calcium and nourishing kidney, bone and muscle strengthening, treating both the principal and secondary aspects of a disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration, can play and promote that bony spur is softening, the effect of atrophy, can fundamentally cure hyperosteogeny, solved problems of the prior art.
The present invention solves the problems of the technologies described above the technical scheme that is adopted to be: a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration, make one day dosage by following raw material medicaments.
Prescription: Spina Gleditsiae 10 grams, Radix Clematidis 10 grams, Radix Glycyrrhizae 5 grams, Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 10 grams, rhizoma sparganic 10 grams, Eupolyphaga Seu Steleophaga 5 grams, Rhizoma Curcumae Longae 10 grams, Cortex Acanthopancis 6 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams.
Usage: be decocted in water for oral dose twice on the one.One month is a course of treatment.
Pharmacological action:
Spina Gleditsiae: search wind, draw out pus by applying a plaster to the affected part, detumescence, evacuation of pus.Control carbuncle, sore, leprosy, tinea skin ulcer, placenta retention.
Radix Clematidis: wind-damp dispelling, the meridian dredging, expectorant saliva, the hypochondriac lump of loosing.Control gout, insensitive impediment, chills and pain of the waist and kness, tetanus, tonsillitis, all a fishbone or other bone caught in the throat pharynxs.
Radix Glycyrrhizae: and middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.Control laryngopharynx swelling and pain, peptic ulcer, ulcer sores is separated poison of drug and alimentary toxicosis.
Radix Rehmanniae: heat clearing away, removing heat from blood promotes the production of body fluid.Control the epidemic febrile disease impairment of YIN, big hot excessive thirst, crimson tongue, coma, macule is spitted blood, epistaxis, the asthenia hectic fever due to YIN-deficiency, hemoptysis is quenched one's thirst, constipation, metrorrhagia.
Radix Paeoniae Rubra: clots absorbing, pain relieving, removing heat from blood, detumescence.Control the stagnant amenorrhea of the stasis of blood, the hernia abdominal mass is gathered, stomachache, hypochondriac pain, epistaxis, dysentery, discharging fresh blood stool, conjunctival congestion, carbuncle.
Rhizoma sparganic: removing blood stasis, circulation of qi promoting, removing food stagnancy, pain relieving.The Zhi lumps in the chest and abdomen, coagulation of QI-blood, trusted subordinate's pain, the side of body expands painful down, amenorrhea, postnatal blood stasis stomachache, traumatic injury.
Eupolyphaga Seu Steleophaga: removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.Be used for the muscles and bones folding and hinder blood stasis amenorrhea, lump in the abdomen mass in the abdomen.
Rhizoma Curcumae Longae: removing blood stasis, circulation of qi promoting is stimulated the menstrual flow, pain relieving.Control trusted subordinate's feeling of fullness distending pain, brachialgia ， mass in the abdomen, women's blood stasis amenorrhea, puerperal, the stasis of blood was stopped stomachache, injury from falling down, carbuncle.
Cortex Acanthopancis: wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt.Control anemofrigid-damp arthralgia, the muscles and bones contraction is anxious, lumbago, sexual impotence, skin ulcer cellulitis toxic swelling, traumatic injury impairment caused by overstrain.
Rhizoma Drynariae: the kidney invigorating, invigorate blood circulation hemostasis.Control suffer from a deficiency of the kidney chronic diarrhea and lumbago, rheumatic arthralgia, toothache, tinnitus, traumatic injury sprain and contusion, bone injury, appendicitis, alopecia areata, clavus.
Caulis Spatholobi: blood circulation promoting and blood stasis dispelling, have enrich blood, invigorate blood circulation, the effect of collateral dredging.Control soreness of waist and knee joint, paralysis and numbness, menoxenia.
After the present invention mixed said medicine, its drug effect synergism had been obtained significant curative effect in the therapeutic process of lumbar vertebra hyperosteogeny.
Model case is as follows:
Case one, Qiu Zhiqiang, man, 70 years old, people from Anhui.It is numb that pain in the lumbar region, sciatic nerve are moved towards.Hospital diagnosis: L4～5 waist gap turn narrow bony spur.Pain in the lumbar region disappears after taking an our course of treatment, uses up second course of treatment, the complete obiteration of lumbago and skelalgia pain, and activity is fully recovered freely.
Case two, Zhou Yue, woman, 66 years old, Cantonese.Seat, stand above waist half an hour pain just, numb, the string pain of shank during walking, evening, lumbago severity often can't be fallen asleep.Hospital is diagnosed as: lumbar vertebra 1-5 is hyperosteogeny in various degree, waist 3-4 stenosis of disc space.After taking the sleep in evening of a we's aftersensation course of treatment, flank pain obviously alleviates, and patient's sensation is no more than one hour on foot after two courses of treatment of taking medicine, and does not have fiber crops pain symptom substantially; Use up lumbago after the 3rd course of treatment, lower limb fiber crops symptom is eliminated fully.
Case three, Liao Ping, woman, 70 years old, people from Heilungkiang.Clinical symptoms: lumbago, can not bend over, the lower limb string pain.Hospital diagnosis: lumbar vertebra hyperosteogeny.The patient took this medicine after ten days, and patient's lumbago begins to alleviate, and used up after the course of treatment, and the patient feels that lumbago alleviates, and had bent over also not bitterly; After the patient used up the medicine of two courses of treatment, shank pain phenomenon was almost eliminated, and waist also can be free movable, uses up and fully recover behind the medicament the 3rd course of treatment.
The specific embodiment
Embodiment one: a kind of Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration, make one day dosage by following raw material medicaments.Prescription: Spina Gleditsiae 10 grams, Radix Clematidis 10 grams, Radix Glycyrrhizae 5 grams, Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 10 grams, rhizoma sparganic 10 grams, Eupolyphaga Seu Steleophaga 5 grams, Rhizoma Curcumae Longae 10 grams, Cortex Acanthopancis 6 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams.
Usage: be decocted in water for oral dose twice on the one.One month is a course of treatment.
Claims (1)
1. a Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny for oral administration is characterized in that the crude drug of making effective ingredient by following weight is: Spina Gleditsiae 10 grams, Radix Clematidis 10 grams, Radix Glycyrrhizae 5 grams, Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 10 grams, rhizoma sparganic 10 grams, Eupolyphaga Seu Steleophaga 5 grams, Rhizoma Curcumae Longae 10 grams, Cortex Acanthopancis 6 grams, Rhizoma Drynariae 30 grams, Caulis Spatholobi 45 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101152868A CN101199793B (en) | 2007-12-17 | 2007-12-17 | Chinese medicine compound oral administration for treating lumbar hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101152868A CN101199793B (en) | 2007-12-17 | 2007-12-17 | Chinese medicine compound oral administration for treating lumbar hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199793A CN101199793A (en) | 2008-06-18 |
| CN101199793B true CN101199793B (en) | 2010-06-16 |
Family
ID=39515276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101152868A Expired - Fee Related CN101199793B (en) | 2007-12-17 | 2007-12-17 | Chinese medicine compound oral administration for treating lumbar hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199793B (en) |
-
2007
- 2007-12-17 CN CN2007101152868A patent/CN101199793B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199793A (en) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101664480B (en) | Chinese herbal medicine medicament for treating hyperosteogeny | |
| CN103191382B (en) | Medicine for treating Bi syndrome and preparation method thereof | |
| CN101507802A (en) | Medicine for treating ankylosing spondylitis | |
| CN103720851B (en) | A kind of Chinese medicine decoction for the treatment of hyperosteogeny | |
| CN101199613B (en) | Traditional Chinese medicine composition for treating lumbar hyperosteogeny | |
| CN104324093A (en) | Traditional Chinese medicine composition for treating hyperosteogeny and preparation method of traditional Chinese medicine composition | |
| CN103599404A (en) | Traditional Chinese medicinal decoction for treating cervical spondylosis | |
| CN103127375B (en) | Chinese materia medica preparation for treating osteoporosis | |
| CN102091169B (en) | Traditional Chinese medicine capsule capable of tonifying liver and kidney, promoting blood circulation by removing blood stasis, dispelling wind, cold and dampness | |
| CN104225487A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN101199793B (en) | Chinese medicine compound oral administration for treating lumbar hyperosteogeny | |
| CN101810747B (en) | Chinese medicinal preparation for treating cervical spondylosis and lumbar disc herniation | |
| CN105412626A (en) | Medicine preparation for treating cervical spine bone hyperplasia and application of medicine preparation | |
| CN102284056B (en) | Chinese medicinal pill for treating cervical spondylosis | |
| CN105687944A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis | |
| CN101530522B (en) | Traditional Chinese medicine preparation for treating wind-cold-dampness pain | |
| CN105920341A (en) | Plaster for treating bone injury diseases and preparation method of plaster | |
| CN101028472B (en) | Oral Chinese medicinal composition for treating lumbocostal overstrain | |
| CN1899564B (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN108030870A (en) | It is a kind of to treat protrusion of lumber intervertebral disc and the plaster of bone fracture and preparation method thereof | |
| CN105213815A (en) | Chinese medicine composition being used for the treatment of cervical spondylosis and preparation method thereof | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN103479840B (en) | Chinese herbal composition for treating cervical, lumbar and bone hyperplasia | |
| CN100400084C (en) | External remedy for treating hyperosteogeny, prolapse of intervertebral disc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANG BO Free format text: FORMER OWNER: MOU PEICHAO Effective date: 20100412 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Shang Bo Inventor after: Mou Peichao Inventor before: Mou Peichao |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MOU PEICHAO TO: SHANG BO MOU PEICHAO Free format text: CORRECT: ADDRESS; FROM: 250014 NO.20, SHUNGENG ROAD, LIXIA DISTRICT, JINAN CITY, SHANDONG PROVINCE TO: 252600 NO.306, JIANKANG STREET, LINQING CITY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20100412 Address after: 252600 Shandong Province Linqing City health Street No. 306 Applicant after: Shang Bo Address before: 250014 No. 20 Shun Road, Lixia District, Shandong City, Ji'nan Province Applicant before: Mou Peichao |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100616 Termination date: 20101217 |